Snezna Rogelj, PhD
Professor
Biology
- snezna.rogelj@nmt.edu
- 575 - 835 - 5608
- Jones Annex 315
- Fall 2020 office hours by phone - Tues & Thurs 5-6 pm, Fri 4-5 pm
Education
Ph.D. Biochemistry, 1985 Dissertation: Action of Retinoic Acid and cAMP in the
Differentiation of F9 Teratocarcinoma and B16-F1 Melanoma Cell Lines
Boston University School of Medicine
Summer Physiology Course at Woods Hole Marine Biological Laboratory, 1982
B.S. Physics with Emphasis on Astronomy, 1976, Ohio State University
Dissertation: Action of Retinoic Acid and cAMP in the Differentiation of F9 Teratocarcinoma and B16-F1 Melanoma Cell Lines
Honors
U.S. Department of Energy's Defense Programs Early Career Scientist and Engineer Award.
1999.
Outstanding New Mexico Tech Professor, 2009
NMT Distinguished Research Award, 2017
- Research Assistant Professor of Pathology, University of New Mexico Medical School 1/97 to 6/98) and Research Associate, Department of Pathology at UNM Medical School (93-96). Molecular mechanisms of leukocyte target recognition in the human immune and inflammatory responses.
- Scientist, ASTRA Biomedical Research Center, Bangalore, India (1989-1992). Parasitology: Developed a cell-line from the tapeworm Taenia Solium. Heterologous gene expression in yeast and mammalian cells
- Lecturer, Harvard Medical School, Children's Hospital, Boston, MA. Department of Surgical Research, (1988-1989). Role of growth-factors in tumorigenesis, neovascularization, and the metastatic spread of tumors.
-
Post-Doctoral Fellow, Whitehead Institute at MIT, Cambridge, MA. (1984-1988). Molecular and cell biology of growth factors in cancer. Participated in the cloning of the first anti-oncogene. Graduate Research Assistant, Department of Biochemisty, Boston University School of Medicine, (1979-1984).Technician, Honeywell-Avionics Division in Minniapolis, Minnasota, January-August 1979.Research Assistant, Hematology Department, Ohio State University, Columbus, OH. (1976-1979)Teaching Assistant, Astronomy Department, Ohio State University, Columbus, OH. (1974-1976).
- Manuel Adrian Rubio, MS (2002): Functional Equivalence of Selected Pesticides and Non-Steroidal Anti-Inflammatory Prescription Drugs.
- Amy Michelle Garcia, MS (2002): Mercury Modulates Human Immune Function by Altering the Expression of Leukocyte Adhesion Molecules.
- Karen Cooper, MS (2002): Immunosuppression by Environmental Pollutants via the Loss of L-Selectin.
- Huining Liang, MS (2002): Development of Immuno-PCR Methodologies for High Sensitivity Detection of Pathogenic Proteins.
- Catrina Huff, MS (2003): The Development of a Novel Biosensor for Rapid Detection of Calmodulin Inhibition by Pesticides and Pharmaceutical Drugs.
- Kate Shapland, MS (ABD 2004): Development of Aptamer DNA Methodologies for High Sensitivity Detection of L-selectin Protein./ Signaling Pathways that Lead to the THC-Mediated L-Selectin Shedding.
- Caroline Maynard, MS (2004): Effect of Selected Pharmaceutical Drugs and Environmental Pesticides on Cyclooxygenase I & II activity.
- Kimbery Reiter, Medical Student at UNM; completed Medical School Research Project "Tamoxifen Promotes Leukocyte L-selectin Shedding in an Activation- and Calcium-Independent Manner", (2004).
- Michele Denton, MS (2005): Development of a DNA Tag library for Use in Single-primer Pair, Multiplex PCR Immuno-detection System.
- Nicola Maynard, MS (2005): Development of a Bead-Based Assay with the Capability of Detecting Calmodulin-Binding Compounds via Flow Cytometry.
- Artem Kireev, MS (2005): Synthesis and Comparative Biological Evaluation of Structurally Simplified Analogues of Selected Amaryllydaceae Alkaloids with Potent Anticancer and Antiviral Activities.
- Troylyn Zimmerly, MS (2005): Immuno-PCR Detection of Escerichia coli 0157:H7 and Campylobacter jejuni. Commercial Preparations of Bacitracin are Contaminated with DNase.
- Satya Sai Vaddadhi,, MS (2005, M.S. Mathematics): Effects of Xenobiotic Body Burden on Human Health.
- Kai Shen, MS (2006): Identification of Vaccine-binding Peptides via the Phage Display Technology.
- Tommie McSherry, MS (2006): Biochemical Characterization and Isolation of Degradative Enzymes in Bacitracin.
- Marisol Gonzales,, MS (ABD 2006): Induction of Apoptosis by Tetrahydrocannabinol and Tamoxifen.
- Qiu Jin, MS (2008): Isolation of Vaccinia-binding Peptides using Phage Display Technique.
- Ray Brungard, MS (2008): Improving Hydrophobic Drug Dispersion and Stability using Surfactant-free Suspensions.
- Felicia Navarro, MS (2009) : Investigation of Indone-azo Structural Analogs for Growth Inhibition of Multi-Drug Resistant Staphyloccus aureus.
- Amy Baker-Kireev, MS (2009): "Cellular Stress Response to Titanium Dioxide Nanoparticles.
- Vineet Patel, MS (2009): Isolation and Characterization of Peptides Binding to Influenza Vaccine Using Phage Display.
- Seth Daly, MS (2010) Antibacterial and Synergistic Activity of Substituted Indoles Against Methicillin-Resistant Staphylococcus aureus.
- Indranil Malik, MS (2011) Identification and Characterization of a Novel Antimicrobial Agent Against Drug-resistant Bacteria.
- Robert Johnston, MS (2011) The Anti-proliferative Effects of the Natural Compound ZR2.
- Amanda Thomas Peretti, MS (2012): Novel Podophyllotoxin Analogues: Screening for Toxicity and Modes of Anti-Cancer Activity.
- Paul Bianchi, MS (2012): The mechanism of action and downstream effects of a novel anti-cancer drug Rigidin 8.
- Alexander Mikhalen, MS (2012): Synthesis and Evaluation of Fatty Acid-Containing Heterocyclic Analogues of Podophyllotoxin for Use in Liposomal Drug Delivery Systems.
- Anntherese Romero, MS (2013): Investigation of Natural Product Analogues as New Anticancer Agents.
- Gina Nguyen, MS (2013): Drug-induced Growth Inhibition of Human Glioblastoma.
- Les Edwards, MS (2013): Combination Antimicrobial Therapy: In vitro photodynamic therapeutic and synergistic activity of novel drug candidates.
- Cody Champion, MS (2014): Photodynamic Anti-MRSA Activity of Modified Indoles.
- Temilade Cecelia Ogunro, MS (2014): Effect of Temperature and Ergosterol Content on Batrachochytrium dendrobatidis, MS (Bd) Viability.
- Alex Pendleton, MS (2016): Normalization, Differentiation, and Growth Arrest of Glioblastoma Cells by a Small, Novel Anticancer Molecule AKS7.
- Danielle Turner, MS (2016): Drug Discovery for Chagas Disease.
- Marie Johnson, MS (2017): Bioremediation of the Peroxide Explosive Methyl, Ethyl Ketone Peroxide by Horseradish Peroxidase., MS (Rogelj academic advisor, Paul Calvert, MS (MatE) research advisor)
- James Horne, MS (2017): Experimental and Computational Meta-transcriptomic Tools towards Medical and Environmental Applications. (Rogelj academic advisor, Patrick Chain, MS (LANL) research advisor)
- Talysa Ogas, MS (2017): In vitro characterization of the mechanisms of action of a small novel hydroxamic acid compound in Glioblastoma Multiforme.
- Shishir Acharya , MS (2017): A Study of Environmental Pollutants' and Anti-Candida and Anti-Beta-lactamase Drugs' Toxicities.
- Liam Hallada MS (2018) Proteasome Inhibition. Chemistry research co-advisor Dr. Tello-Aburto.
- Haley Campos, MS (2019): Protective Properties of Cytoplasmic Abundant Heat Soluble 3 Protein. Research co-advisor Dr. DeVeaux.
- Joseph Couls, MS-current: Transcriptomic Response of T. cruzi-infected Human Cells to AKS7-mediated Cure.
- Danielle Turner, PhD BioTechnology (2019): Discovery and Development of Antimicrobial Agents Targeting Multi-drug Resistant Bacterial, Fungal, and Parasitic Pathogens: From the Bench to the Bedside.
1. Azza Ezzat (2009): Teaching Dynamic Interdependence between Teenage Physiology and Behavior.
- Bridget Rutz (M.S. Biology, advisor Dr. Kieft)
- Justin Tibbitts (M.S. Biology, advisor Dr. Kirk)
- Sandy Dunaway (M.S. Biology, advisor Dr. Smoake)
- Joseph Pierce (M.S. Biology, advisor Dr. Smoake)
- Margaret-gail Medina (Ph.D. Materials Eng.advisor Dr. Bond)
- F. Arzum Simsek (Ph.D. Materials Eng. advisor Dr. Bond)
- Rebekkah Silva (M.S. Biology, advisor Dr. Kieft)
- Zhu Fu (M.S. Biology, advisor Dr. Kieft)
- Bridget Rutz (M.S. Biology, advisor Dr. Kieft)
- Sandy Dunaway (M.S. Biology, advisor Dr. Smoake)
- Susan Velarde (M.S. Biology, advisor Dr. Smoake)
- Misty Millison (M.S. Biology, M.S. advisor Dr. Kieft)
- Nikki Beauchamp (M.S. Biology, advisor Dr. Shors)
- Hiashi Cao (Ph.D in Chemistry,, advisor Dr. Heagy)
- Madhuri Manpadi (Ph.D in Chemistry,, advisor Dr. Kornienko)
- Severine Van Slambrouck (Ph.D. in Chemistry, advisor Dr. Steelant)
- Amanda Bernauer (M.S. Biology, advisor Dr. Kieft)
- Angela Dickey (M.S. Chemistry, advisor Dr. Pullin)
- Yujie Jin (M.S. Environmental Engineering advisor Dr. Huang)
- Tamara Hartenberger, (M.S. Biology, advisor Dr. Shors)
- Jeff Bogzevitz (MST Biology, advisor Dr. Shors)
- Ernest Yufenyuy (M.S. Biology, advisor Dr. Kieft)
- Jerimiah (Jeb) Robinson, (M.S. Materials advisor Dr. Majumdar)
- Artem Kireev (Ph.D. Chemistry, advisor Dr. Kornienko)
- Manoj Kumar (Ph.D. in Chemistry, advisor Dr. Zhang)
- Giovanni Luchetti (Ph.D. in Chemistry, advisor Dr. Kornienko)
- Yanyan Guo (Ph.D. candidate in Chemistry, advisor Dr. Zhang)
- Nikolai Edvokimov (Ph.D. in Chemistry, advisor Dr. Kornienko)
- Jacy Gansz (MS in Materials, advisor Dr. Tartis)
- Elizabeth Larkin (MS in Materials, advisor Dr. Tartis)
- Alexander Mikhalin (MS in Biology, advisor Dr. Tartis)
- Ranjith Kumar Meka (PhD in Chemistry, advisor Dr. Heagy)
- Anntherese Romero (MS in Biology, advisor Dr. Magedov)
- Margaret Snell (MS in Mathematics, advisor Dr. Hossain)
- Robert Johnston (PhD in Materials Engineering, advisor Dr. Tartis)
- Alex Kent (PhD in Computer Science and Engineering, advisor Dr. Liebrock)
- Shawn Henry (MS in Chemistry, advisor Dr. Frolova)
- Patrick Illescas (MS in Biology, advisor Dr. Reiss)
- Karen Simmons (MS in Biology, advisor Dr. Kieft)
- Olivia Chavez (MS in Biology, advisor Dr. Kieft)
- Rubi Gurung (PhD in Chemistry, advisor Dr. Piyasena)
- Gayatri Gautam (PhD in Chemistry, advisor Dr. Piyasena)
- Ashley Chavez (MS in Biology, advisor Dr. DeVeaux)
- Liam Hallada (MS in Biology, Chemistry research advisor Dr. Tello-Aburto)
- Bradley Stevens (MS in Biology, Chemistry research advisor Dr. Tello-Aburto)
- Primal Silva (MS in Biology, Neuroscience research advisor Dr. Thompson)
- Ethan Contreras (MS in Biology, Neuroscience research advisor Dr. Thompson)
- Betty Fish (MS candidate in Biology, Neuroscience research advisor Dr. Thompson)
- Ankita Schwarting (MS candidate in Biology, Neuroscience research advisor Dr. Thompson)
- Nelum Perera (PhD candidate in Chemistry, advisor Menake Piyasena)
- Dr. Hongkuan Fan (2001-2002)
- Dr. Hong Tang ( 2004-2009)
- Dr. Megha Khandelwal (2016-2017)
- Dr. Danielle Turner (2019-2021)
Rogelj Patents
- Methods for treatment of resistant cancer
Patent number: 10414778
Abstract: The present disclosure describes a method to treat conditions, including cancer, using compounds that can target resistant cancer cells. The compounds of the invention can decrease the rate of proliferation of drug-resistant cancer cells, such as glioma, lung cancer, and uterine sarcoma.
Inventors: Snežna Rogelj, Liliya Frolova, Alexander Kornienko, Sean Henry
- Antibiotic sensitivity-restoring and photosensitive agents
Patent number: 10239834
Abstract: The present disclosure describes a method to treat conditions, including bacterial infections and cancer, using a photosensitive compound that, upon exposure to white light, can be activated. The photosensitive compound can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria. The photosensitive compounds can also be used to inhibit the proliferation of cancer cells.
Inventors: Snežna Rogelj, Liliya Frolova, Alexander Kornienko, Leslie D. Edwards, Cody Champion, Kailee Zingler, Danielle Nicole Turner
- Frankiamicin A compositions and methods
Patent number: 10010558
Abstract: In one aspect, this disclosure describes a pharmaceutical composition that generally includes frankiamicin A and a pharmaceutically acceptable carrier. In another aspect, this disclosure describes a method of treating a subject having, or at risk of having, a condition caused by a microbial infection treatable with frankiamicin A. Generally, the method includes administering to the subject an amount of frankiamicin A effective to ameliorate at least one symptom or clinical sign of the condition.
Inventors: Charles Melancon, Pamela Hall, Jacob Greenberg, Yasushi Ogasawara, Snežna Rogelj
- Antibiotic sensitivity-restoring and photosensitive agents
Patent number: 9834514
Abstract: The present disclosure describes a method to treat conditions, including bacterial infections and cancer, using a photosensitive compound that, upon exposure to white light, can be activated. The photosensitive compound can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria. The photosensitive compounds can also be used to inhibit the proliferation of cancer cells.
Inventors: Snežna Rogelj, Liliya Frolova, Alexander Kornienko, Leslie D. Edwards, Cody Champion, Kailee Zingler, Danielle Nicole Turner
- Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
Patent number: 9334280
Abstract: A compound having the Formula as follows: wherein R, R1 and R2 are selected from hydrogen, aryl, fused aryl, heteroaryl, saturated carbocylclic, partially saturated carbocyclic, saturated heterocyclic, partially saturated heterocyclic, C1-10 alkyl, haloalkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, alkenylalkyl, alkynylalkyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, nitroalkyl, cyanoalkyl, acetamidoalkyl, and acyloxyalkyl. A process for the preparation thereof is also provided.
Inventors: Igor V. Magedov, Snežna Rogelj, Liliya V Frolova, Alexander Vladimir Kornienko
- Treatment of drug-resistant cancer with 2-aryl-2-(3-indolyl) acetohydroxamates
Patent number: 9206124
Abstract: A pharmaceutical composition, a method of producing same, and a method of providing cancer therapy therein comprising a pharmaceutically acceptable excipient or carrier and a compound Formula 3 as follows: or a pharmaceutically acceptable salt or prodrug thereof, wherein: R1, R2, R3 and R4 are optionally substituted and are hydrogen, haloalkyl, aryl, fused aryl, carbocyclic, a heterocyclic group, a heteroaryl group, C1-10 alkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, nitroalkyl, cyanoalkyl, acetamidoalkyl, acyloxyalkyl, hydroxyl, alkoxy, acetoxy, amino, alkylamino, acetamido.
Inventors: Alexander V. Akensov, Snežna Rogelj, Liliya Frolova, Alexander Kornienko, Gabriel Avilucea
- Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
Patent number: 8946246
Abstract: A compound having the Formula I as follows: wherein R1 and R2 are selected from hydrogen, aryl, fused aryl, heteroaryl, saturated carbocylclic, partially saturated carbocyclic, saturated heterocyclic, partially saturated heterocyclic, C1-10 alkyl, haloalkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, nitroalkyl, cyanoalkyl, acetamidoalkyl, and acyloxyalkyl. A process for the preparation thereof is also provided.
Inventors: Igor V. Magedov, Snežna Rogelj, Liliya Vladlenovna Frolova, Alexander Vladimir Kornienko
- Pyrano [3,2-C] pyridones and related heterocyclic compounds as pharmaceutical agents for treating disorders responsive to apoptosis, antiproliferation or vascular disruption, and the use thereof
Patent number: 8349864
Abstract: A pharmaceutical composition comprising a pharmaceutically acceptable excipient or carrier and a compound Formula I: or a pharmaceutically acceptable salt or prodrug thereof.
Inventors: Alexander Kornienko, Igov V. Magedov, Snežna Rogelj
- Inhibition of cell surface protein disulfide isomerase
Patent number: 6949665
Abstract: The invention provides anti-thiol reagents which inhibit enzyme activity of cell-associated protein disulfide isomerase (PDI) by oxidizing or blocking PDI active site vicinal thiol groups which normally participate in disulfide bond rearrangement of PDI substrates. Inhibition of this PDI function is particularly useful in blocking PDI-mediated entry of HIV or other virions into a host cell, as well as inhibiting lymphocyte traffic through the lymph nodes. The invention further provides an assay for the identification of such PDI inhibitors based on the discovery that inhibitors of the invention also induce
Inventors: Snežna Rogelj, Larry A. Sklar, Robert B. Palmer
- Method for induction of L-selectin shedding
Patent number: 6943268
Abstract: The invention provides anti-thiol reagents which inhibit enzyme activity of cell-associated protein disulfide isomerase (PDI) by oxidizing or blocking PDI active site vicinal thiol groups which normally participate in disulfide bond rearrangement of PDI substrates. Inhibition of this PDI function is particularly useful in blocking PDI-mediated entry of HIV or other virions into a host cell, as well as inhibiting lymphocyte traffic through the lymph nodes. The invention further provides an assay for the identification of such PDI inhibitors based on the discovery that inhibitors of the invention also induce shedding of the leucocyte L-selectin adhesion molecule. The invention additionally provides for suppression of inflammation and of lymph node entry by calmodulin antagonists that, like PDI inhibition, cause leukocyte L-selectin shedding.
- Method for induction of L-selectin shedding
Patent number: 6498189
Abstract: The invention provides anti-thiol reagents which inhibit enzyme activity of cell-associated protein disulfide isomerase (PDI) by oxidizing or blocking PDI active site vicinal thiol groups which normally participate in disulfide bond rearrangement of PDI substrates. Inhibition of this PDI function is particularly useful in blocking PDI-mediated entry of HIV or other virions into a host cell, as well as inhibiting lymphocyte traffic through the lymph nodes. The invention further provides an assay for the identification of such PDI inhibitors based on the discovery that inhibitors of the invention also induce shedding of the leucocyte L-selectin adhesion molecule. The invention additionally provides for suppression of inflammation and of lymph node entry by calmodulin antagonists that, like PDI inhibition, cause leukocyte L-selectin shedding.
Inventors: Snežna Rogelj, Teresa A. Bennett, Larry A. Sklar
Publications List
[63] Desymmetrization of Cyclopropenes via the Potassium-Templated Diastereoselective 7-exo-trig Cycloaddition of Tethered Amino Alcohols toward Enantiopure Cyclopropane-Fused Oxazepanones with Antimycobacterial Activity.Maslivetc, Vladimir A; Turner, Danielle N; McNair, Kimberly N; Frolova, Liliya; Rogelj, Snežna; Maslivetc, Anna A; Aksenov, Nicolai A; Rubina, Marina; Rubin, Michael; The Journal of organic chemistry. 83 (10):5650-5664 (2018)
[64] Fate, transformation, and toxicological impacts of pharmaceutical and personal care products in surface waters Maldonado-Torres, Sabino; Gurung, Rubi; Rijal, Hom; Chan, Andrew; Acharya, Shishir; Rogelj, Snežna; Piyasena, Menake; Rubasinghege, Gayan. Environmental health insights 12, 1178630218795836 (2018)
[65] Abiotic degradation and environmental toxicity of ibuprofen: Roles of mineral particles and solar radiation. Rubasinghege, Gayan; Gurung, Rubi; Rijal, Hom; Maldonado-Torres, Sabino; Chan, Andrew; Acharya, Shishir; Rogelj, Snežna; Piyasena, Menake. Water research 131:22-32 (2018)
[66] Metal-templated assembly of cyclopropane-fused diazepanones and diazecanones via exo-trig nucleophilic cyclization of cyclopropenes with tethered carbamates. Maslivetc, Vladimir A; Frolova, Liliya V; Rogelj, Snežna; Maslivetc, Anna A; Rubina, Marina; Rubin, Michael. The Journal of organic chemistry 83(22):13743-13753 (2018)
[67] Activity of natural and synthetic polygodial derivatives against Trypanosoma cruzi amastigotes, trypomastigotes and epimastigotes. Turner, Danielle N; Just, Jeremy; Dasari, Ramesh; Smith, Jason A; Bissember, Alex C; Kornienko, Alexander; Rogelj, Snežna. Natural product research. 1-4 (2019)
[68] Spectroscopic Study of a Photoactive Antibacterial Agent: 2, 3-Distyrylindole.Rajapaksha, Ruwini D; Banet, Matthias; Champion, Cody; Frolova, Liliya V; Rogelj, Snežna; Choudhury, Pabitra; Ranasinghe, Mahinda I. The Journal of Physical Chemistry A 122(4):937-945 (2018)
[69] Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins: Exploration of the N3 and N9 Positions and Interaction with Multi-Drug Resistance Proteins. Ramesh Dasari, Andrzej Błauż, Derek C Medellin, Roaa M Kassim, Carlos Viera, Maximo Santarosa, Danielle Turner, Alet E van der Westhuyzen, Willem AL van Otterlo, Taryn Olivas, Tugba Yildiz, Tania Betancourt, Charles B Shuster, Snežna Rogelj, Błażej Rychlik, Todd Hudnall, Liliya V Frolova, Alexander Kornienko. ChemMedChem 14(3)322 (2019)
[70] Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors. Niroula, Doleshwar; Hallada, Liam P; Le Chapelain, Camille; Ganegamage, Susantha K; Dotson, Devon; Rogelj, Snežna; Groll, Michael; Tello-Aburto, Rodolfo. European journal of medicinal chemistry 157: 962-977 (2018)
[71] Photoactivated 2, 3-distyrylindoles kill multi-drug resistant bacteria. Edwards, Leslie; Turner, Danielle; Champion, Cody; Khandelwal, Megha; Zingler, Kailee; Stone, Cassidy; Rajapaksha, Ruwini D; Yang, Jing; Ranasinghe, Mahinda I; Kornienko, Alexander; Bioorganic & medicinal chemistry letters 28(10): 1879-1886 (2018)
[72] Photo-physical properties of substituted 2, 3-distyryl indoles: Spectroscopic, computational and biological insights. Rajapaksha, Ruwini D; Turner, Danielle N; Vigil, Jade; Frolova, Liliya V; Altig, Jeffrey A; Rogelj, Snežna; Ranasinghe, Mahinda I. Journal of Photochemistry and Photobiology A: Chemistry 376:73-79 (2019)
[73] A toxicological study on photo-degradation products of environmental ibuprofen: Ecological and human health implications. Ellepola, Nishanthi; Ogas, Talysa; Turner, Danielle N; Gurung, Rubi; Maldonado-Torres, Sabino; Tello-Aburto, Rodolfo; Patidar, Praveen L; Rogelj, Snežna; Piyasena, Menake E; Rubasinghege, Gayan; Ecotoxicology and environmental safety 188: 109892 (2020)
[74] Synergistic action of substituted indole derivatives and clinically used antibiotics against drug-resistant bacteria. Turner, Danielle N; Edwards, Leslie; Kornienko, Alexander; Frolova, Liliya V; Rogelj, Snežna; Future Microbiology 15(8):579-590 (2020)
[75] Effects of physiological deficits in pineal melatonin on Triple Negative Breast Cancer. Dearing, Carley G; Silva, Primal D; Turner, Danielle N; Fish, Betty A; Contreras, Ethan O; Schwarting, Zuri A; Sena, Johnny; Schilkey, Faye D; Bearer, Elaine L; Wilkinson, Stephen D; Snežna Rogelj, Stewart Thompson. BioRxiv (2020)